Pricing Log in Create free account

20/20 Biolabs Inc. (AIDX) vs Nuwellis, Inc. (NUWE)

20/20 Biolabs Inc. and Nuwellis, Inc. are both Medical Devices companies. 20/20 Biolabs Inc. and Nuwellis, Inc. are of similar size ($2.5M and $2.5M). Nuwellis, Inc. has the higher net margin (−125.6% vs −298.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Nuwellis, Inc. leads on 9 and 20/20 Biolabs Inc. on 4.

Valuation

Metric AIDX NUWE Medical Devices median
P/E n/m n/m 24.94
P/S 0.99 0.01 2.66
P/B 1.33 n/m 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA 0.39 n/m 11.42
EV/Sales (0.67) 0.01 2.76
Earnings yield (436.45%) (17,689.52%) (12.66%)
Free cash flow yield (201.49%) (13,863.65%) (7.18%)

Profitability

Metric AIDX NUWE Medical Devices median
Gross margin 32.06% 69.69% 57.76%
Operating margin (198.15%) (142.87%) (14.84%)
Net margin (298.16%) (125.57%) (14.45%)
Free cash flow margin (200.12%) (140.67%) (5.70%)
Return on equity 0.00% 205.50% (10.56%)
Return on assets (211.61%) (123.52%) (17.26%)
Return on invested capital 0.00% 0.00% (5.22%)

Growth

Metric AIDX NUWE Medical Devices median
Revenue growth (TTM) — 8.36% 10.41%
EPS growth (last fiscal year) 34.28% 92.81% 28.17%
Revenue growth, 5-year CAGR — 2.14% 15.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AIDX NUWE Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 1.99 1.97 2.67
Net debt to EBITDA 0.11 0.10 0.54

Dividend

Metric AIDX NUWE Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric AIDX NUWE Medical Devices median
Market cap 2.50m 2.52m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack